Frequency of Prescription Claims for Drugs that May Interact with Janus kinase Inhibitors Among Patients with Rheumatoid Arthritis in the US
mediaposted on 2021-01-06, 16:24 authored by Alison Walton, Jim Paik, Amanda Quebe, Carol L. Kannowski, Casey Choong, Seth Anderson, Justin K. Owensby
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.